Fig. 3From: Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapyA PPI network of TR as analyzed using geneMANIA. B Top ten hub genes analyzed using the degree method of CytoHubbaBack to article page